Compounds > fomesafen
Page last updated: 2024-08-23

fomesafen and Atherosclerotic Parkinsonism

fomesafen has been researched along with Atherosclerotic Parkinsonism in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's5 (50.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuno, S; Mizuta, E; Sasa, M; Yoshida, O; Yoshimura, N1
Dietz, V1
Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N1
Iakimovskiĭ, AF1
Fujiwara, S; Kuriwaka, R; Matsumoto, T; Mitsui, T; Nishida, Y1
Beckley, DJ; Bloem, BR; Remler, MP; Roos, RA; Singh, J; Wolfe, NS1
Piha, SJ; Rinne, JO; Rinne, UK; Seppänen, A1
Barbeau, A; Boyer, H; Buu, NT; Dallaire, L; de Lanney, LE; Irwin, I; Langston, EB; Langston, JW; Veilleux, F1
Barbeau, A; Buu, NT; Dallaire, L; Poirier, J; Rucinska, E1
Osuide, G1

Reviews

1 review(s) available for fomesafen and Atherosclerotic Parkinsonism

ArticleYear
Reflex behavior and programming in Parkinson's disease.
    Advances in neurology, 1993, Volume: 60

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Electromyography; Haplorhini; Humans; Muscle Rigidity; Muscle Tonus; Muscles; Parkinson Disease; Parkinson Disease, Secondary; Postural Balance; Posture; Proprioception; Reflex

1993

Other Studies

9 other study(ies) available for fomesafen and Atherosclerotic Parkinsonism

ArticleYear
The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Neuropharmacology, 1993, Volume: 32, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dopamine Agents; Ergolines; Macaca fascicularis; Male; Parkinson Disease, Secondary; Quinpirole; Reflex; Urinary Bladder; Urination

1993
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1

    Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination

1998
[Multiple microinjections of haloperidol in rat globus pallidus induce vegetative components of parkinsonian syndrome].
    Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 125, Issue:6

    Topics: Animals; Autonomic Nervous System; Avoidance Learning; Dopamine Antagonists; Globus Pallidus; Haloperidol; Male; Microinjections; Motor Activity; Neostriatum; Parkinson Disease, Secondary; Rats; Rats, Wistar; Reaction Time; Reflex; Syndrome

1998
Loss of postural reflexes in long-term occupational solvent exposure.
    European neurology, 2002, Volume: 47, Issue:2

    Topics: Adult; Air Pollutants, Occupational; Atrophy; Cerebellum; Homovanillic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Occupational Diseases; Parkinson Disease, Secondary; Postural Balance; Posture; Receptors, Dopamine; Reflex; Solvents

2002
Postural reflexes in patients on long-term neuroleptic medication.
    Clinical neurology and neurosurgery, 1991, Volume: 93, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Electromyography; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Posture; Reaction Time; Reflex; Schizophrenia

1991
Autonomic dysfunction in recent onset and advanced Parkinson's disease.
    Clinical neurology and neurosurgery, 1988, Volume: 90, Issue:3

    Topics: Aged; Autonomic Nervous System Diseases; Cardiovascular System; Female; Heart Function Tests; Humans; Male; Parkinson Disease, Secondary; Reflex

1988
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Life sciences, 1985, Mar-18, Volume: 36, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Catecholamines; Disease Models, Animal; Melanophores; Motor Activity; Movement; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Pyrogallol; Ranidae; Reflex; Salamandridae; Skin Pigmentation

1985
Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.
    Life sciences, 1985, Oct-21, Volume: 37, Issue:16

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drug Interactions; Epinephrine; Melanophores; Motor Activity; Norepinephrine; Paraquat; Pargyline; Parkinson Disease, Secondary; Pigmentation; Posture; Pyridines; Pyridinium Compounds; Rana pipiens; Reflex

1985
Proceedings: The use of the chick in pharmacological screening tests.
    West African journal of pharmacology and drug research, 1974, Volume: 2, Issue:1

    Topics: Animals; Animals, Newborn; Chickens; Drug Evaluation, Preclinical; Parkinson Disease, Secondary; Reflex

1974